Mya Schiess
UTMOVE Movement Disorders Fellowship Program Director · University of Texas Health Science Center at Houston
Credentials: · · ·
History
PresentUTMOVE Movement Disorders Fellowship · University of Texas Health Science Center at Houston
- Present
UTMOVE Annual Symposium · University of Texas Health Science Center at Houston
- 1972–1976
Research
Phosphorylated α-synuclein in Parkinson's disease
Science Translational Medicine · 2012 · 249 citations
JAMA · 2021 · 144 citations
Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease
Journal of Neurology · 2007 · 124 citations
8 papers · 1 as a fellow
7 papers
5 papers · 5 as a fellow
4 papers
4 papers · 2 as a fellow
4 papers
4 papers
3 papers · 3 as a fellow
Clinical trials
- 2020–2023
Principal investigator · Completed · Phase 2
Mya Schiess
- 2017–2019
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Principal investigator · Completed · Phase 1
The University of Texas Health Science Center, Houston
- 2009–2011
Early Parkinson's Disease (PD) Cross-Sectional
Principal investigator · Terminated
The University of Texas Health Science Center, Houston
- 2009–2025
RBD Longitudinal as Prognostic for PD
Principal investigator · Unknown
The University of Texas Health Science Center, Houston